TRICARE Pharmacy Program RFI (Draft Section C & H)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEFENSE HEALTH AGENCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

-

NAICS

524114 - Direct Health and Medical Insurance Carriers

Classification Code

Q201

Additional Details
Set Aside

None

Place of Performance

UNITED STATES

SourceSAM
Documents3
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a Special Notice as part of its acquisition planning for the forthcoming TRICARE Pharmacy Program (TPharm6) contract. This notice serves as a Request for Information (RFI) and is specifically aimed at soliciting industry feedback on two critical draft documents: Section C (Statement of Work) and Section H (Special Contract Requirements). The intent is to refine and enhance the program requirements and contractual framework for the next generation of the TRICARE Pharmacy Program, which provides pharmacy benefits to eligible military beneficiaries across the United States. The scope of this procurement activity encompasses the administration and management of pharmacy benefits under the TRICARE program, as indicated by the associated NAICS code 524114 (Direct Health and Medical Insurance Carriers) and Product Service Code Q201. The DHA is seeking input from qualified vendors with relevant experience in large-scale health and pharmacy benefit management, with the goal of ensuring that the final contract documents reflect industry best practices, operational feasibility, and the highest standards of beneficiary care. Key objectives of this RFI include gathering detailed industry insights on the draft Statement of Work and Special Contract Requirements. The DHA is particularly interested in identifying potential challenges, innovative solutions, and recommendations for improvement that will inform the final solicitation. Expected deliverables at this stage are comprehensive written comments, questions, and suggestions pertaining to the draft documents. Additionally, the DHA is offering the opportunity for one-on-one meetings with interested vendors during the summer of 2026, providing a forum for more in-depth discussion and clarification. Interested parties are instructed to submit their feedback and requests for one-on-one meetings no later than May 11, 2026, at 12:00 PM Mountain Time. Written responses should be sent via email to [email protected], with the company name and "Draft Documents Response" in the subject line. Requests for meetings should be submitted through the provided online form. These interactions are designed to ensure that the final solicitation is well-informed by industry expertise and positioned for successful contract execution. The place of performance for the anticipated contract is within the United States. The contracting entity is the Defense Health Agency, a federal office within the Department of Defense. The primary points of contact for this notice are Viktoria Reed ([email protected], 303-676-3648) and Brooke Wolfe ([email protected], 303-676-3799). This notice is currently active and can be accessed via the official SAM.gov portal (Opportunity ID: 156ca6f8b67d4fad8f588de797d49fb6). Contractors with expertise in health insurance and pharmacy benefit management are encouraged to review the draft documents and participate in this critical phase of acquisition planning. No set-aside requirements or special procurement considerations are specified at this stage, as the notice is focused on market research and industry engagement to shape the final solicitation. This RFI represents a significant opportunity for industry stakeholders to influence the structure and requirements of a major federal healthcare contract that will impact the delivery of pharmacy services to military beneficiaries nationwide.